Jose Luis Labandeira-Garcia

25PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsAutonomic nervous systemMolecular targetsCharacterisation of biological macromoleculesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 09, 2025
Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson's disease patients.

Laura Camacho-Meño, Carmen M Labandeira, Susana B Bravo

|Oct 29, 2025
Involvement of Neuroinflammation and Oxidative Stress in L-DOPA-Induced Dyskinesia in Parkinson's Disease: Role of Renin-Angiotensin System and ROCK Pathway.

Ana Muñoz, Andrea López-López, Jannette Rodríguez-Pallares

|Jul 02, 2025
Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease.

Jannette Rodríguez-Pallares, Lucia A Garcia-Crivaro, Juan A Parga

|Jun 26, 2025
Renin-Angiotensin System Autoantibody Network in Parkinson's Disease Patients.

Carmen M Labandeira, Laura Camacho-Meño, Paula Aracil-Pastor

|Nov 15, 2024
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Rafael Rivas-Santisteban, Ana Muñoz, Jaume Lillo

|May 12, 2024
Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson's disease models.

Ana I Rodríguez-Pérez, Pablo Garrido-Gil, Maria García-Garrote

Pageof 5